Does CONR seriously think it can get around the patent issues, or is it simply trying to demonstrate efficacy of the stent in hopes of licensing it to BSX? I don't get it.
The obstacle to discovery is the illusion of knowledge.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.